Xia Q - Search Results

1

Functionalized Multi-Walled Carbon Nanotubes for Targeting Delivery of Immunostimulatory CpG Oligonucleotides Against Prostate Cancer.

Xia Q, Gong C, Gu F, Wang Z, Hu C, Zhang L, Qiang L, Ding X, Gao S, Gao Y. Xia Q, et al. J Biomed Nanotechnol. 2018 Sep 1;14(9):1613-1626. doi: 10.1166/jbn.2018.2605. J Biomed Nanotechnol. 2018. PMID: 29958555

2

A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer.

Li Y, Gao Y, Gong C, Wang Z, Xia Q, Gu F, Hu C, Zhang L, Guo H, Gao S. Li Y, et al. Among authors: xia q. Nanomedicine. 2018 Oct;14(7):1973-1985. doi: 10.1016/j.nano.2018.05.020. Epub 2018 Jun 20. Nanomedicine. 2018. PMID: 29935333

3

Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer.

Gu F, Hu C, Xia Q, Gong C, Gao S, Chen Z. Gu F, et al. Among authors: xia q. J Nanopart Res. 2018;20(11):303. doi: 10.1007/s11051-018-4407-z. Epub 2018 Nov 12. J Nanopart Res. 2018. PMID: 30524190 Free PMC article.

4

Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer.

Gu F, Hu C, Cao W, Li C, Xia Q, Gao Y, Liu Y, Gao S. Gu F, et al. Among authors: xia q. Int J Nanomedicine. 2022 Sep 20;17:4401-4417. doi: 10.2147/IJN.S377702. eCollection 2022. Int J Nanomedicine. 2022. PMID: 36164553 Free PMC article.

5

Co-delivery of the autophagy inhibitor si-Beclin1 and the doxorubicin nano-delivery system for advanced prostate cancer treatment.

Hu C, Gu F, Gong C, Xia Q, Gao Y, Gao S. Hu C, et al. Among authors: xia q. J Biomater Appl. 2022 Feb;36(7):1317-1331. doi: 10.1177/08853282211060252. Epub 2021 Dec 2. J Biomater Appl. 2022. PMID: 34856824

6

Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment.

Gong C, Hu C, Gu F, Xia Q, Yao C, Zhang L, Qiang L, Gao S, Gao Y. Gong C, et al. Among authors: xia q. J Control Release. 2017 Nov 28;266:272-286. doi: 10.1016/j.jconrel.2017.09.042. Epub 2017 Oct 5. J Control Release. 2017. PMID: 28987884

7

Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against drug-resistance in breast cancer.

Hu C, Gu F, Tai Z, Yao C, Gong C, Xia Q, Gao Y, Gao S. Hu C, et al. Among authors: xia q. Oncotarget. 2016 Sep 20;7(38):61832-61844. doi: 10.18632/oncotarget.11451. Oncotarget. 2016. PMID: 27557520 Free PMC article.

8

Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.

Gu F, Hu C, Tai Z, Yao C, Tian J, Zhang L, Xia Q, Gong C, Gao Y, Gao S. Gu F, et al. Among authors: xia q. Sci Rep. 2016 Nov 2;6:36281. doi: 10.1038/srep36281. Sci Rep. 2016. PMID: 27805051 Free PMC article.

9

Silk-engineered bioactive nanoparticles for targeted alleviation of acute inflammatory disease via macrophage reprogramming.

Liu R, Zhao E, Wang Y, Zuo H, Li L, Xia Q, He H. Liu R, et al. Among authors: xia q. J Nanobiotechnology. 2025 Jan 10;23(1):11. doi: 10.1186/s12951-024-03055-6. J Nanobiotechnology. 2025. PMID: 39794773

10

Machine Learning-Driven Prediction, Preparation, and Evaluation of Functional Nanomedicines Via Drug-Drug Self-Assembly.

Zhang C, Yuan Y, Xia Q, Wang J, Xu K, Gong Z, Lou J, Li G, Wang L, Zhou L, Liu Z, Luo K, Zhou X. Zhang C, et al. Among authors: xia q. Adv Sci (Weinh). 2025 Jan 10:e2415902. doi: 10.1002/advs.202415902. Online ahead of print. Adv Sci (Weinh). 2025. PMID: 39792782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,895 results

Search Page

Filters